News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
China Phase I Agreement Represents Important…
Washington, D.C. (January 15, 2020) – BIO President and CEO Jim Greenwood released the following statement today regarding the signing of Phase One of the trade agreement with China: “Trade issues with China have long been a priority for BIO and…
Washington State’s Clean Fuels Program Takes to…
Today, the Sustainable Aviation Fuels (SAF) Producers Group together with the Biotechnology Innovation Organization (BIO) and the Low Carbon Fuels Coalition (LCFC) issued the following statement commending Alaska Airlines’ support for including…
USMCA Is a Missed Opportunity to Create Positive…
The Biotechnology Innovation Organization (BIO) released the following statement in response to House passage of the revised USMCA: “The revised USMCA was a huge missed opportunity to create a positive framework for a dynamic and leading…
Letters, Testimony, & Comments
Select Committee on Climate Crisis: BIO Comments…
The Biotechnology Innovation Organization (BIO) is pleased to respond to the Select Committee's Request for Information (RFI) on how supportive public policy can help biotechnology reduce greenhouse gas emissions, enhance carbon sequestration,…
Office of New Drugs: BIO Comments on Promoting…
January 7, 2020 Re: Docket No. FDA–2019-N-3453: Promoting Effective Drug Development Programs: Opportunities and Priorities for the Food and Drug Administration's Office of New Drugs Dear Sir/Madam: The Biotechnology Innovation Organization (BIO…
Clinical Outcomes and Endpoints: BIO Comments on…
January 4, 2020 Re: Docket No. FDA–2019-N-5157: 2019 Public Meeting on Center for Drug Evaluation and Research Standard Core Sets: Clinical Outcome Assessments and Endpoints Grant Program. Dear Sir/Madam: The Biotechnology Innovation Organization…
Amicus Briefs
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
BIO Files Amicus Brief on Case Addressing…
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 
Blog Posts
Placeholder Image
January 23, 2020
As a new college graduate in the early 80’s, Shawn Tomasello knew one thing for sure. She wanted a career in an industry that would constantly change; one that would keep her on her toes; allow her to always be learning…
Placeholder Image
January 24, 2020
Friday, January 24, is celebrated as National Peanut Butter Day.  I'm a huge fan of peanut butter. I'm more of a crunchy fan over smooth, but I'll take it either way. For a while there a few brands even had extra…
China flag pinned to China on a map
January 23, 2020
Phase one of the China trade deal has been inked. For farmers across rural America, China’s commitment to purchase more agricultural products like corn and soybeans as part of this agreement is a positive sign. But,…